2016 Hematological Malignancies

HD8: Second Neoplasia

15-year estimate [95%-CI] EF: 17.1% [13.2% to 21.1%] IF: 14.2% [10.4% to 18.1%] diff: -2.9% [-8.4% to 2.6%] Median observation time 153 months

151

288

426

532

 Trend towards increased SIR with EF: 3.6 (2.9-4.0) vs. 2.6 (2.0-3.3) compared to the age- and sex-specific incidence in the German general population